2nd Annual Bioanalytical and Formulation Summit

We are pleased to invite you to the 2nd Annual Bioanalytical and Formulation Summit scheduled on May 17th - 18th, 2018 in Barcelona, Spain.

This premier B2B event provides the appropriate platform to engage and discuss ideas with your peers, while facilitating a professional atmosphere and environment for good company representation and development.

The Summit will shed light on the recent practice and novel developments in bioanalytical and formulation strategies.

It is an honour and privilege to invite you to participate in this Summit. We look forward to welcoming you at the Summit in Barcelona in May!

Key Practical Learning Points of the Summit:

  • Novel bioanalytical developments for large and small molecules, peptides, and oligonucleotides
  • Better utilizing analytical strategies for novel proteins and antibodies
  • Overcoming challenges presented by increased complexity and diversity of novel therapeutic modalities
  • Advanced practice in immunogenicity assessments
  • The key roles of formulation and new orthogonal analytical methods for the success of biopharmaceuticals
  • Early formulation and characterization strategies

Who Should Attend:

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders, and Managers specialising in:

  • Bioanalytics
  • Bioassay development
  • Quality control
  • Quality Assistance R&D
  • CMC
  • Principle Scientist
  • Method Development
  • Biophysical Analytics
  • Characterisation Production & Analysis
  • Analytical Development
  • Preclinical Development
  • Formulation Scientist
  • Protein Analytics
  • Protein Biophysics & Formulation Bioanalytical Assay
  • Pharmacology
  • BioFormulations
  • Researcher
  • Immunogenicity
  • Biomarkers
  • Antibody & Biologics Discovery/Development
  • Manufacturing/CMC
  • Molecular Biology
  • Medicinal Chemistry
  • Antibody Drug Conjugates (ADCs)
  • Small-Molecule Drug Conjugates
  • Large-Molecule Drug Conjugates
  • Immunoconjugates
  • Monoclonal Antibodies (mAbs)
  • Target ID & Validation
  • Clinical Development
  • Toxicology
  • Cancer
  • Oncology
  • Haematology
  • Antibody-Based Therapeutics
  • Peptide-drug conjugates
  • Nanoparticles/Nanobodies
  • Diabodies/Minibodies
  • PKPD
  • Biotherapeutics
  • Immunotherapeutics
  • Chemotherapeutics
  • Neurodegeneration Therapeutics
  • Rare Diseases
Media partners